Delays in fast track antiretroviral therapy initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa.

: We report data from an observational cohort of South African children living with HIV less than 12 years of age eligible for fast track antiretroviral therapy (rapid) initiation. We found that less than half of children eligible for rapid antiretroviral therapy initiation based on immunologic and disease status started treatment within 1 week.

Ductal closure in infants under 6 kg including premature infants using Amplatzer duct occluder type two additional sizes: a single-centre experience in South Africa.

Background: This is a report on percutaneous closure of patent ductus arteriosus (PDA) using Amplatzer Duct Occluder type two additional sizes (ADO II AS) in patients under 6 kg.

Methods: Prospective data were collected and a review of Patients' records was conducted. Demographics, and angiographic and clinical outcomes are reported in this article.

HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.

Introduction: There are limited data on viral suppression (VS) in children with HIV receiving antiretroviral therapy (ART) in routine care in low-resource settings. We examined VS in a cohort of children initiating ART in routine HIV care in Eastern Cape Province, South Africa.

Methods: The Pediatric Enhanced Surveillance Study enrolled HIV-infected ART eligibility children zero to twelve years at five health facilities from 2012 to 2014.

Patent ductus arteriosus closure using Occlutech Duct Occluder, experience in Port Elizabeth, South Africa.

Background: Percutaneous closure of patent ductus arteriosus (PDA) has become standard therapy. Experience with the Occlutech® Duct Occluder is limited.

Methods: Data regarding ductal closure using Occlutech® Duct Occluder were reviewed and prospectively collected.